Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation.

Source:http://linkedlifedata.com/resource/pubmed/id/8121459

N. Engl. J. Med. 1994 Apr 7 330 14 956-61

Download in:

View as

Triples

General Info

PMID
8121459